DenialHelpUnderstand your treatment-resistant depression — rtms, spravato, ect denial. Build a reviewable appeal.
Upload the denial notice, verify the extracted facts, identify missing evidence, and prepare a package for treating-clinician review. The notice and applicable rules determine the available route and deadline.
Start my appeal→
See how it worksThe denial notice
Confirm the payer's stated reason, plan language, dates, and review rights from the actual notice.
Facts and evidence
Keep extracted information linked to its source. Unknown facts stay unknown until you or the clinician confirms them.
Route and review
Classify the next step, verify any deadline, and identify what requires treating-clinician review or signature.
Four clear stages.
Upload your denial — and any clinical records you have
Take a photo, scan, or upload PDFs of the denial letter. Adding labs, prior PA letters, or visit notes makes the appeal stronger — but the denial alone is enough to start.
Confirm a few facts
We pre-fill what was extracted. You confirm, correct, or leave it unknown.
We draft your appeal
A source-linked draft and evidence checklist for treating-clinician review.
Your doctor signs and files
We email the letter to you. Your doctor reviews, signs, and submits.
Common questions
Can I appeal a denied insurance claim for Treatment-resistant depression — rTMS, Spravato, ECT?
The denial notice and governing plan or program determine whether and how the decision can be challenged. DenialHelp first classifies the route, then organizes the relevant facts and sources. Filing dates vary and must be verified against the actual notice.
What does DenialHelp cost for a Treatment-resistant depression — rTMS, Spravato, ECT appeal?
$39 for a first-level appeal. Other review levels use the current prices shown on the pricing page. The refund promise concerns the described deliverable, not the insurer's decision.
Who reviews and signs the Treatment-resistant depression — rTMS, Spravato, ECT appeal letter?
The patient's treating physician reviews and signs the appeal letter before it is submitted to the insurer. DenialHelp drafts the letter; the patient and prescribing physician are responsible for submission. We do not file appeals on behalf of patients.
What treatments are covered under Treatment-resistant depression — rTMS, Spravato, ECT?
NeuroStar TMS Therapy (10 Hz figure-8 coil) — FDA-cleared Oct 2008 for MDD after failure of >=1 antidepressant at adequate dose/duration; standard 6-wk 30-session course (titrate to 36), Brainsway Deep TMS H1 coil — FDA-cleared Jan 2013 for MDD; H7 coil cleared Aug 2018 for OCD; H4 coil cleared Aug 2020 for smoking cessation, Magstim Horizon / Rapid2 figure-8 rTMS — FDA-cleared 2015 for MDD, MagVenture MagPro / TMS Therapy — FDA-cleared 2015 for MDD; iTBS protocol cleared Aug 2018, Intermittent theta-burst stimulation (iTBS, 3-min protocol) — FDA-cleared Aug 2018 (NeuroStar TrueAir + MagVenture); non-inferior to standard 10 Hz per Blumberger Lancet 2018 (THREE-D), SAINT / SNT (Stanford Accelerated Intelligent Neuromodulation Therapy) — FDA 510(k) cleared Sep 6, 2022 to Magnus Medical; 10 iTBS sessions/day x 5 days, fMRI-guided sgACC-targeted, Accelerated rTMS (multiple sessions/day, non-SAINT compressed protocols), Spravato (esketamine) intranasal — FDA Mar 5, 2019 for TRD (with oral antidepressant); FDA Aug 3, 2020 for MDD with acute suicidal ideation/behavior; FDA Jan 21, 2025 monotherapy for TRD; REMS-restricted
Ready to fight your denial?
Our free pre-payment review runs before checkout. Refund requests made within 7 calendar days of payment are processed automatically; later requests are reviewed under the Terms. A refund policy is not a promise of a payer outcome.
Start my appeal→